Cite
HARVARD Citation
Yang, L. et al. (n.d.). 2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis. European journal of cancer. pp. S524-. [Online].